Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WQ5S
|
|||
| Former ID |
DCL001029
|
|||
| Drug Name |
U-99363E
|
|||
| Synonyms |
U 99363; U 99363E; U-99363; N-(1-benzylpiperidin-4-yl)-3-ethoxy-N-methylpyridin-2-amine; 3-Ethoxy-N-methyl-N-(1-(phenylmethyl)-4-piperidinyl)-2-pyridinylamine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Preclinical | [1] | |
| Company |
Pfizer
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H27N3O
|
|||
| Canonical SMILES |
CCOC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=CC=C3
|
|||
| InChI |
1S/C20H27N3O/c1-3-24-19-10-7-13-21-20(19)22(2)18-11-14-23(15-12-18)16-17-8-5-4-6-9-17/h4-10,13,18H,3,11-12,14-16H2,1-2H3
|
|||
| InChIKey |
VNSBZWKWQFCKGO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 170856-57-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.